Turn Therapeutics TTRX
NASDAQ TTRX
$10.18 +0.03 (+0.30%)
At close: Oct 22, 2026 · 4:00 PM EDT

Turn Therapeutics (TTRX) Accounts Payables (2024 - 2026)

Updated

Turn Therapeutics (TTRX) reported Accounts Payables of $2.61 million for Q2 2026, up 12.5% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Accounts Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Turn Therapeutics posted Accounts Payables of $2.93 million, up 338.9% from FY2024.

  • By year, Accounts Payables came in at $667,272 in FY2024.
  • Five-year quarterly Accounts Payables spans a low of $667,272 in Q4 2024 and a high of $2.93 million in Q4 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.32 million (Q1 2026), $2.93 million (Q4 2025) and $2.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 9.32 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 33.30 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 3.83 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 22.89 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 674.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 4.58 Bn
10 Turn Therapeutics 303.54 Mn 276.65 Mn - 2.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.61 Mn
Mar 31, 2026 2.32 Mn
Dec 31, 2025 2.93 Mn
Sep 30, 2025 2.26 Mn
Dec 31, 2024 667,272.00
API Access

Turn Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=TTRX&period=max&api_key=YOUR_API_KEY